drug

tiopronin

Marketedupdated 2mo ago

by Mission Pharmacal Co

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Nov 14, 2038

~12.4 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

Nov 14, 2038method-of-use (U-3441)US 11458104
Nov 14, 2038method-of-use (U-3441)US 11458104

FDA exclusivities (3)

Jun 28, 2026ODE-267Orphan Drug (7y)
Jun 28, 2026ODE*ODE*
Jun 28, 2026ODE*ODE*

Data sources

ClinicalTrials.gov

last refreshed 11m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying tiopronin

phase2A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defectscompletedn=10